Literatur:

1. Pleschka S. et al. Testing of the anti­viral acti­vity of ANGOCIN® Anti-Infekt‑N mixture on influ­enza virus A/Hamburg/01/09 (H1N1v) repli­ca­tion on MDCK-II-cells and A549-cells via Focus- and HA-Assay; Publi­ka­tion in Vorbereitung

2. Herz C. et al. Evalua­tion of an aqueous extract from horse­ra­dish root (Armo­racia rusti­cana radix) gainst lipo­po­lys­ac­cha­ride-induced cellular inflamm­a­tion reac­tion. Evidence-Based Comple­men­tary and Alter­na­tive Medi­cine, Volume 2017, Article ID 1950692 (2017)

3. Marzocco A. et al. Anti-inflamm­a­tory acti­vity of horse­ra­disch (Armo­racia rusti­cana) root extracts in LPS-stimu­lated macro­phages. Food Func. 6 (12): 3778–88 (2015)

4. Dey M. et al. In-vitro and in-vivo anti-Inflamm­a­tory acti­vity of a seed prepa­ra­tion contai­ning phen­ethyl­isothio­cya­nate. Journal of phar­ma­co­logy and expe­ri­mental thera­peu­tics 317(1): 326–333 (2006)

5. Tsai J. et al. Suppres­sion of inflamm­a­tory media­tors by cruci­fe­rous vege­table-derives indole-3-carbi­nole and phenyl­ethyl­isothio­cya­nate in lipo­po­lys­ac­cha­ride-acti­vated macro­phages. Media­tors of Inflamm­a­tion (2010)

6. Boya­na­palli S.S. et al. Nrf2 knockout atte­nuates the anti-Inflamm­a­tory effects of phen­ethyl­Isothio­cya­nate and curcumin. Chem. Res. Toxicol., 27 (12), pp 2036–2043 (2014)

7. Cheung K.L. et al. Syner­gi­stic effect of combi­na­tion of phen­ethyl­isothio­cya­nate and sulfora­phane or curcumin and sulfora­phane in the inhi­bi­tion of inflamm­a­tion. Phar­maceu­tical Rese­arch, Volume 26, Issue 1, pp 224–231(2009)

8. Tran H. et al. Nast­ur­tium (Indian cress, Tropaeolum majus nanum) dually blocks the COX an LOX pathway in primary human immune cells. Phyto­me­di­cine 23: 611–620 (2016)

9. Marton M.R. et al. Deter­mi­na­tion of bioac­tive, free isothio­cya­nates from a gluco­si­no­late-contai­ning phyto­the­ra­peutic agent: A pilot study with in vitro models and human inter­ven­tion. Fito­ter­apia 85: 25–34 (2013)

10. Lee M.L. et al. Benzyl isothio­cya­nate exhi­bits anti-inflamm­a­tory effects in murine macro­phages and in mouse skin. J Mol Med 87: 1251–1261 (2009)

11. Dufour V. et al. The anti­bac­te­rial proper­ties of isothio­cya­nates. Micro­bio­logy 161: 229–243 (2015)

12. Aires A. et al. The anti­mi­cro­bial effects of gluco­si­no­lates and their respec­tive enzy­matic hydro­lysis products on bacteria isolated from the human intestinal tract. Journal of applied Micro­bio­logy 106:2086–2095 (2009)

13. Borges A. et al. Anti­bac­te­rial acti­vity and mode of action of selected gluco­si­no­lates hydro­lysis products against bacte­rial patho­gens. J Food Sci Technol 52 (8): 4737- 48 (2015)

14. Dias C. et al. Anti­mi­cro­bial acti­vitiy of isothio­cya­nates from cruci­fe­rous plants against methi­cillin-resistant Staphy­lo­coccus aureus (MRSA). Int. J. Mol. Scji. 15: 19552–19561 (2014)

15. Conrad A. et al. Broad spec­trum anti­bac­te­rial acti­vity of a mixture of isothio­cya­nates from nast­ur­tium (Tropaeoli majoris herba) and horse­ra­dish (Armo­ra­ciae rusti­canae radix). Drug Res 63: 65–68 (2013)

16. Conrad A. et al. In-vitro-Unter­su­chungen zur anti­bak­te­ri­ellen Wirk­sam­keit einer Kombi­na­tion aus Kapu­zi­ner­kres­se­kraut (Tropaeoli majoris Herba) und Meer­ret­tich­wurzel (Armo­ra­ciae rusti­canae radix), Drug Res 56/12: 842–849 (2006)

17. Kure­pina, N. et al.: Growth-inhi­bi­tory acti­vity of natural and synthetic isothio­cya­nates against repre­sen­ta­tive human micro­bial patho­gens, Journal of applied micro­bio­logy 115, 943–954 (2013)

18. Konsen­sus­pa­pier zum inter­dis­zi­pli­nären Round­table: Die effek­tive Behand­lung von Atem­wegs­in­fek­tionen – Status quo und alter­na­tive Thera­pie­an­sätze mit Isothio­cya­naten (2014)

19. https://www.tk.de/tk/pressemitteilungen/bundesweite-pressemitteilungen/951490, Stand: Nov. 2017

20. Goos K.-H. et al. Wirk­sam­keit und Verträg­lich­keit eines pflanz­li­chen Arznei­mit­tels mit Kapu­zi­ner­kres­sen­kraut und Meer­ret­tich bei akuter Sinu­s­itis, akuter Bron­chitis und akuter Blasen­ent­zün­dung im Vergleich zu anderen Thera­pien unter den Bedin­gungen der tägli­chen Praxis. Drug Res 56: 249–257 (2006)

21. Goos K.-H. et al. Aktu­elle Unter­su­chungen und Verträg­lich­keit eines pflanz­li­chen Arznei­mit­tels mit Kapu­zi­ner­kres­sen­kraut und Meer­ret­tich bei akuter Sinu­s­itis, akuter Bron­chitis und akuter Blasen­ent­zün­dung bei Kindern im Vergleich zu anderen Anti­bio­tika. Arzneim.-Forsch./Drug Res. 57, No. 4, 238–246 (2007)

22. Commu­nity herbal mono­graph and assess­ment report on Marru­bium vulgare L., herba, EMA/HMPC (2012)

23. Yousefi K. et al. Marru­bium vulgare, L. metha­nolic extract inhi­bits inflamm­a­tory response and prevents cardio­myo­cyte fibrosis in isopro­te­renol-induced acute myocar­dial infarc­tion in rats. BioIm­pacts 4(1):21–27 (2014)

24. Kanyonga PM. et al. Assess­ment of metha­nolic extract of Marru­bium vulgare for anti­in­flamm­a­tory, anal­gesic and anti-micro­bio­logic acti­vi­ties. J. Chem. Pharm. Res. 3(1):199–204 (2011)

25. Jorge VG. et al. Vasor­ela­xant Effect of Etha­nolic Extracts from M. Vulgare: Mexican Medi­cinal Plant as Poten­tial Source for Bioac­tive Mole­cules Isola­tion. Indo Global Journal of Phar­maceu­tical Sciences 3(1): 1–5 (2013)

26. Schl­emper V. et al. Anti­s­pas­modic effects of hydro­al­co­holic extract of Marru­bium vulgare on isolated tissues. Phyto­me­di­cine Sep; 3(2): 211–6 (1996)